1. <b id="e5ksh"></b>
    <b id="e5ksh"></b>
    1. <nav id="e5ksh"></nav>
      <thead id="e5ksh"><dl id="e5ksh"></dl></thead>

         
        副所院長王建祥帶領的研究團隊在《Blood》發表新成果

          副所院長王建祥帶領的研究團隊在國際血液學領域的核心期刊《Blood》發表題為"TBLR1 fuses to retinoid acid receptor alpha in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia”的研究論文。

           英文摘要

           The majority of acute promyelocytic leukemia (APL) cases are characterized by PML-RARα fusion gene. Although PML-RARα fusion gene can be detected in more than 98% of APL cases, RARα is also found to be fused with other partner genes, which are also related to all-trans retinoic acid (ATRA) dependent transcriptional activity and cell differentiation. In this study, we identified a novel RARα fusion gene, TBLR1-RARα (GenBank KF589333), in a rare case of APL with a t(3;17)(q26;q21), t(7;17)(q11.2;q21) complex chromosomal rearrangement. To our knowledge, TBLR1-RARα is the tenth RARα chimeric gene which has been reported up to now. TBLR1-RARα contained the B-F domains of RARα, exhibited a distinct subcellular localization. It could form homodimers and also heterodimers with RXRα. As a result, TBLR1-RARα exhibited diminished transcriptional activity by recruitment of more transcriptional corepressors compared with RARα. In the presence of pharmacological doses of ATRA, TBLR1-RARα could be degraded and its homodimerization was abrogated. Moreover, when treated with ATRA, TBLR1-RARα could mediate the dissociation and degradation of transcriptional corepressors, consequent transactivation of RARα target genes and cell differentiation induction in a dose- and time-dependent manner.

          點擊進入《Blood》網頁(速度有點慢,請耐心等待)

          手機閱讀

           
        網站導航 | 聯系我們 | 使用幫助 | 網站聲明


        主辦:中國醫學科學院血液學研究所血液病醫院  技術支持:北方網
          備案序號:津ICP備05001070號
        建議使用IE6.0以上瀏覽器,分辨率1024*768

        野狼舍区华人第一社区